tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market
Advertisement

Sonnet BioTherapeutics Holdings (SONN) Ownership - Who Owns Sonnet BioTherapeutics Holdings?

Compare
635 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
62,649Institution0.89%370,882
29,386Institution0.42%173,965
22,356Insider0.32%132,348
15,367Insider0.22%90,973
14,116Insider0.20%83,567
10,547Insider0.15%62,438
10,375Insider0.15%61,420
9,643Insider0.14%57,087
9,374Insider0.13%55,494
6,446Insider0.09%38,160

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
29,386Institution0.42%173,965
1,840Institution0.03%10,893

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
62,649Institution0.89%286,932

FAQ

Who Owns Sonnet BioTherapeutics Holdings (SONN)?
Currently, no data Available
What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by institutional investors?
Currently, no data Available
What percentage of Sonnet BioTherapeutics Holdings (SONN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Sonnet BioTherapeutics Holdings (SONN)?
Vanguard owns the most shares of Sonnet BioTherapeutics Holdings (SONN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis